<DOC>
	<DOCNO>NCT00608699</DOCNO>
	<brief_summary>To test ability GSK256073 block niacin-induced flushing GSK256073 niacin co-administered single dos HVTs .</brief_summary>
	<brief_title>A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Flushing</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Adult males 18 55 year age , inclusive . Healthy subject Body weight &gt; 50 kg ( 110 pound ) body mass index ( BMI ) 19 31 : Subjects QTc &lt; 450 msec screen History significant cardiac arrhythmia Active peptic ulcer disease ( PUD ) and/or history PUD History gout and/or hyperuricemia History Gilbert 's syndrome History recurrent indigestion , stomach upset diarrhea History rare ( yearly less ) flush Recurrent skin rash psoriasis History kidney stone</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Flushing</keyword>
	<keyword>GSK256073A ,</keyword>
	<keyword>Dose Escalation ,</keyword>
	<keyword>Immediate Release Niacin ,</keyword>
</DOC>